Lypolytic activity (glycerol release, mg/ml) measured in adipocytes culture medium after 2 h incubation with isoproterenol or 8-Cl-cAMP. Lypolytic activity.

Slides:



Advertisements
Similar presentations
Source: International Chair on Cardiometabolic Risk Fatty Acid Metabolism in Humans Michael Jensen, MD Division of Endocrinology.
Advertisements

Necdin–E2F4 interaction provides insulin-sensitizing effect after weight loss induced by gastric bypass surgery  Zehra N. Pamuklar, M.D., Ph.D., Jiegen.
RESULTS OF THE RIMONABANT IN OBESITY (RIO) PROGRAM AT 1 YEAR
Volume 164, Issue 2, Pages (October 2002)
Plasma insulin concentrations (A) and insulin secretion rates (B) in response to molar increments of plasma glucose concentration during the graded glucose.
Valsartan Protects Pancreatic Islets and Adipose Tissue From the Inflammatory and Metabolic Consequences of a High-Fat Diet in Mice by Banumathi K. Cole,
Activation of Transient Receptor Potential Vanilloid Type-1 Channel Prevents Adipogenesis and Obesity by Li Li Zhang, Dao Yan Liu, Li Qun Ma, Zhi Dan Luo,
by José J. Fuster, Noriyuki Ouchi, Noyan Gokce, and Kenneth Walsh
Ectopic fat and cardiometabolic and vascular risk
Distribution of the absolute percentage differences of each basal rate estimate to final basal rates. Distribution of the absolute percentage differences.
Fibrosis and Adipose Tissue Dysfunction
Insulin and glucagon secretion: nondiabetic and diabetic subjects.
Volume 26, Issue 2, Pages e3 (August 2017)
Necdin–E2F4 interaction provides insulin-sensitizing effect after weight loss induced by gastric bypass surgery  Zehra N. Pamuklar, M.D., Ph.D., Jiegen.
Frequency of potential risk of hypoglycemia for each estimate method, defined as a percentage difference between the estimate and final basal rate. Frequency.
Distribution of the percentage differences of each basal rate estimate to final basal insulin rates. Distribution of the percentage differences of each.
Comparison of cytokine profiles induced by ChiLob 7/4 and TLR ligands in ex vivo whole-blood stimulation assays. Comparison of cytokine profiles induced.
(A–B) Box plot representing the median relative expression of CD300LG mRNA in skeletal muscle (A) and in SAT (B) by CD300LG genotype. (A–B) Box plot representing.
Abdominal adipose tissue depots and pancreatic volume in a 29-year-old non-obese (BMI: 21.9 kg/m2) patient with type 2 diabetes, images obtained using.
Visceral fat area (VFA, cm2), subcutaneous fat area (SFA, cm2), body mass index (BMI, kg/m2) and waist circumference (WC, cm) levels according to the quartiles.
Mean daily glucose concentration and frequency of hypoglycemia in long-term care residents with type 2 diabetes. Mean daily glucose concentration and frequency.
The correlation between visceral fat area (VFA) and body mass index (BMI) in patients with type 2 diabetes. The correlation between visceral fat area (VFA)
Intracellular injection of apSyn enhances evoked neurotransmitter release from C1 neuron somata cultured under low-release conditions. Intracellular injection.
SGC activity in isolated aortic smooth muscle cells from control (□) and diabetic (STZ) (■) rats was determined under basal conditions and after in vitro.
Hyperinsulinemic-euglycemic clamps revealed that obese TPL2KO mice have an improved insulin sensitivity compared with obese WT mice. Hyperinsulinemic-euglycemic.
Cellularity of epididymal adipose tissue.
PKA regulatory subunit (R1A, R2A, and R2B) mRNA expression in human adipose tissue from obese and nonobese subjects as assessed by real-time PCR. Data.
A: Total collagen content by Sirius red staining in cardiac tissue of control (SD) animals. A: Total collagen content by Sirius red staining in cardiac.
A working hypothesis for insulin action in the brain.
Suggested model of integrated regulation of CCL2 by miRNAs and TFs in human adipocytes and macrophages. Suggested model of integrated regulation of CCL2.
Rosiglitazone induces Pdk4 expression in rat and human adipose tissue ex vivo and in 3T3–F442A adipocytes. Rosiglitazone induces Pdk4 expression in rat.
Glucose infusion rate required to maintain the hyperglycemic clamp during the experimental period in sedentary and exercised dogs receiving basal or elevated.
Serum adiponectin is significantly lower in obese gestational diabetes mellitus (GDM) women compared with obese women at 26 weeks of gestation. Serum adiponectin.
GLUT4 LXRE is required for downregulation of adipose GLUT4 mRNA during fasting and diet-induced obesity. GLUT4 LXRE is required for downregulation of adipose.
Skeletal muscle characteristics of HFD-induced obese mice.
IGF-II and IGFBP-5 rescue the atrophy of myotubes induced by adipocytes. IGF-II and IGFBP-5 rescue the atrophy of myotubes induced by adipocytes. A–D:
Relationships between NEFA release from subcutaneous abdominal adipose tissue and fat mass (A) and fasting insulin (B) in different groups of subjects.
Forefoot peak plantar pressure in diabetic patients without and with mild, moderate, and severe peripheral neuropathy. *Severe and moderate neuropathy.
Plasma levels of GLP-1 are increased in patients with critical illness and correlate with disease severity. Plasma levels of GLP-1 are increased in patients.
Unlabeled and tracer glucocorticoids in plasma from arterialized samples and veins draining skeletal muscle and subcutaneous adipose tissue. Unlabeled.
Showing significant positive correlation of circulating plasma DPP4 levels with total intra-abdominal adipose tissue volume in patients with T2DM (A) and.
A–E: Mechanisms underlying the blunted adiponectin secretion in adipocytes from obese/type 2 diabetic mice. A–E: Mechanisms underlying the blunted adiponectin.
Effect of berberine on white adipose tissue mass.
Glycogen synthase and glycogen phosphorylase activities after in vivo AICAR treatment. Glycogen synthase and glycogen phosphorylase activities after in.
Lower SNS activity in WAT of fasted Ugcgf/f//CamKCreERT2 mice.
A and B: Intracellular cAMP levels and lipolysis in adipocytes from chow-fed and HFD-fed mice. A and B: Intracellular cAMP levels and lipolysis in adipocytes.
A–E: Adiponectin secretion is stimulated via adrenergic pathways in a Ca2+-independent manner. A–E: Adiponectin secretion is stimulated via adrenergic.
Clustering of fat mass loss profiles in obese subjects and relation with scWAT fibrosis. Clustering of fat mass loss profiles in obese subjects and relation.
Mean fasting C-peptide levels (for all subjects [A]) and mean peak C-peptide levels (all subjects [B], adolescents [C], and adults [D])after mixed-meal.
Ionized-to-total magnesium (Mg) and calcium (Ca) ratios are lower in patients on hemodialysis than those in patients not on dialysis. Ionized-to-total.
Inhibition of glucagon-induced glycogenolysis in human primary hepatocytes. Inhibition of glucagon-induced glycogenolysis in human primary hepatocytes.
DPP4 release of explants obtained from adipose tissue of lean controls and obese patients before and after bariatric surgery, and linear correlation with.
ATL-801 treatment increases insulin sensitivity in KKAY mice.
Odor-induced brain responses in patients with type 2 diabetes (A) and normal control subjects (B) (with AlphaSim correction, voxel level: P < 0.001, cluster.
Total plasma BCAA (A) and C3 and C5 acylcarnitine (AC) (B) concentrations in the basal state and during insulin infusion in obese subjects before and after.
CPPED1 (A) and PPARγ2 (B) mRNA expressions in cultured SGBS cells during adipocyte differentiation. CPPED1 (A) and PPARγ2 (B) mRNA expressions in cultured.
The lack of effect of denatonium to stimulate insulin release in the absence of extracellular Ca2+ or in the presence of 10 μmol/l nitrendipine. The lack.
Food intake in response to central infusion of glucose (squares) or insulin (triangles) and in response to successive central infusion of insulin, insulin.
PKA inhibitors do not markedly affect the potentiation of glucose-induced insulin release by GLP-1. PKA inhibitors do not markedly affect the potentiation.
Forest plot and pooled estimates of the effect of NAFLD on the risk of incident diabetes in 16 eligible studies, stratified by length of follow-up (FU)
DPP-4 enhances M1 polarization and inhibits M2 polarization in macrophages in an ROS-dependent manner. DPP-4 enhances M1 polarization and inhibits M2 polarization.
Effect of GSK-3 inhibitors on basal and insulin-stimulated glucose uptake in human muscle cells. Effect of GSK-3 inhibitors on basal and insulin-stimulated.
Metabolic parameters in the three groups of patients during l-arginine infusion. Metabolic parameters in the three groups of patients during l-arginine.
Effect of nucleoside analogues on DNA repair response initiated by 4-HC. Effect of nucleoside analogues on DNA repair response initiated by 4-HC. A, CLL.
Correlation between serum visfatin concentrations and the clinical stage (A) and tumor size (B, C) of HCCs. A and B, the correlations were determined by.
Upper panel: For performance of the 10-g monofilament test, the device is placed perpendicular to the skin, with pressure applied until the monofilament.
Cellular pharmacology of F-ara-A and Cl-F-ara-A.
Exercise-induced changes in urinary adiponectin levels and difference in urinary adiponectin multimers between patients with diabetes mellitus (DM) and.
WM volume did not show the expected increase in volume with age in children with type 1 diabetes (●), in contrast with HC subjects (▲) who showed the (expected)
An adipocyte in an obese individual is contrasted with a dysfunctional adipocyte in congenital lipodystrophy. An adipocyte in an obese individual is contrasted.
Presentation transcript:

Lypolytic activity (glycerol release, mg/ml) measured in adipocytes culture medium after 2 h incubation with isoproterenol or 8-Cl-cAMP. Lypolytic activity (glycerol release, mg/ml) measured in adipocytes culture medium after 2 h incubation with isoproterenol or 8-Cl-cAMP. Isoproterenol and 8-Cl-cAMP induced an increase in basal lipolytic activity in visceral (A) and subcutaneous (B) both in obese and nonobese subjects. Basal and stimulated lipolytic activity was significantly lower in visceral adipose tissue from obese patients than in samples from nonobese subjects. *P < 0.05 vs. basal; §P < 0.05 vs. nonobese. Giovanna Mantovani et al. Diabetes 2009;58:620-626 ©2009 by American Diabetes Association